SeaStar Medical Holding Corporation (ICU)

NASDAQ: ICU · IEX Real-Time Price · USD
0.734
+0.026 (3.67%)
At close: Mar 28, 2024, 4:00 PM
0.760
+0.026 (3.53%)
After-hours: Mar 28, 2024, 7:59 PM EDT

Company Description

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.

The company offers inflammatory response to fend off infections and repair damaged tissue in the body.

It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.

SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.

SeaStar Medical Holding Corporation
SeaStar Medical Holding logo
Country United States
Founded 2018
Industry Biotechnology
Sector Healthcare
Employees 9
CEO Eric Schlorff

Contact Details

Address:
3513 Brighton Blvd, Suite 410
Denver, Colorado 80216
United States
Phone 844-427-8100
Website seastarmedical.com

Stock Details

Ticker Symbol ICU
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001831868
ISIN Number US81256L1044
Employer ID 85-3681132
SIC Code 3841

Key Executives

Name Position
Eric Schlorff Chief Executive Officer, President and Executive Director
Dr. H. David Humes M.D. Co-Founder and Managing Director
Colonel Kevin Chung FACP, M.D. Chief Medical Officer
David A. Green CPA, M.B.A. Chief Financial Officer
Tom Mullen Vice President of Operations and Product Development

Latest SEC Filings

Date Type Title
Mar 27, 2024 8-K/A [Amend] Current report
Mar 27, 2024 8-K Current Report
Mar 27, 2024 8-K Current Report
Mar 8, 2024 8-K Current Report
Mar 5, 2024 424B3 Prospectus
Mar 5, 2024 424B3 Prospectus
Mar 5, 2024 424B3 Prospectus
Mar 5, 2024 424B3 Prospectus
Mar 5, 2024 424B3 Prospectus
Mar 5, 2024 424B3 Prospectus